Part D Precription Drug

The $9 billion in Extra Cash From Medicare

Posted on

On January 4, 2019 the Wall Street Journal published a powerful article written by Joseph Walker and Christopher Weaver describing how Medicare Part D insurers kept $9.1 billion more in taxpayer funds than they would have had their estimates been accurate from 2006 to 2015. In the WSJ  article, the writers do a deep dive […]

Medicare

The “Medicare and You” 2018 Guide is Available

Posted on

The 2018 Medicare Annual Enrollment Period begins October 15 and ends December 7, 2017. During this period, I will be hosting a complimentary, no-obligation, Community Meetings to discuss Original Medicare, Medicare Supplement and Prescription Drug plans as well as Medicare Part C (Medicare Advantage) plans including the difference between HMO and PPO. The “Medicare & […]

Part D Precription Drug

Is the new Novo Nordisk “improved” insulin worth a 60-70% price hike? The market says ‘no.’

Posted on

My clients regularly ask why brand name medications are so expensive. This great article by WSJ reporter Denise Roland helps explain the game. “In traditional marketing, a product line extension is the use of an established brand name for a new item with new flavors, forms, colors, added ingredients, package sizes.” Novo Nordisk repackaged its […]